Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.

[1]  C. Fraga.  Plant phenolics and human health: biochemistry, nutrition and pharmacology. , 2009 .

[2]  M. Meydani,et al.  Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. , 2003, The American journal of clinical nutrition.

[3]  A.V. Kovalyov.  An O , 1995, Proceedings of Tenth International Symposium on Intelligent Control.

[4]  G. Maskarinec,et al.  Phytoestrogens in human biomatrices including breast milk. , 1999, Biochemical Society transactions.

[5]  G. Maskarinec,et al.  Three measures show high compliance in a soy intervention among premenopausal women. , 2003, Journal of the American Dietetic Association.

[6]  Shuying S Li,et al.  High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart , 2005, British Journal of Nutrition.

[7]  O. Arisaka,et al.  Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. , 2002, The Journal of nutrition.

[8]  J. Sabaté,et al.  Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes. , 2008, The American journal of clinical nutrition.

[9]  J. Steichen,et al.  Bone mineralization and growth in term infants fed soy-based or cow milk-based formula. , 1987, The Journal of pediatrics.

[10]  Y. Ishimi,et al.  Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial , 2007, Menopause.

[11]  M. Messina.  A brief historical overview of the past two decades of soy and isoflavone research. , 2010, The Journal of nutrition.

[12]  D. Kim,et al.  Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. , 1998, Biological & pharmaceutical bulletin.

[13]  A. Pantuck,et al.  Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. , 2004, Japanese journal of clinical oncology.

[14]  A. Franke,et al.  Isoflavones from soya foods are more bioavailable in children than adults , 2007, British Journal of Nutrition.

[15]  R. A. King,et al.  Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. , 1998, The American journal of clinical nutrition.

[16]  K. Barnhart,et al.  Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. , 2001, JAMA.

[17]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[18]  J. Lampe,et al.  Urinary Equol Excretion with a Soy Challenge: Influence of Habitual Diet , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  K. Setchell,et al.  Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. , 2003, The Journal of nutrition.

[20]  M. Pike,et al.  Childhood Soy Intake and Breast Cancer Risk in Asian American Women , 2009, Cancer Epidemiology Biomarkers & Prevention.

[21]  M. Adams,et al.  Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. , 2008, Atherosclerosis.

[22]  E. John,et al.  Sources of Phytoestrogen Exposure among Non-Asian Women in California, USA , 2000, Cancer Causes & Control.

[23]  G. Maskarinec,et al.  Equol production changes over time in pre-menopausal women , 2011, British Journal of Nutrition.

[24]  X. Shu,et al.  Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. , 2009, The American journal of clinical nutrition.

[25]  J. Lampe.  Is equol the key to the efficacy of soy foods? , 2009, The American journal of clinical nutrition.

[26]  Jun Wang,et al.  Genistein action in the prepubertal mammary gland in a chemoprevention model. , 2002, Carcinogenesis.

[27]  Mitch Dowsett,et al.  Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  S. Schwartz,et al.  Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  Peiyu Wang,et al.  Prevalence of the Equol-Producer Phenotype and Its Relationship with Dietary Isoflavone and Serum Lipids in Healthy Chinese Adults , 2010, Journal of epidemiology.

[30]  H. Adlercreutz,et al.  The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption. , 2005, The Journal of nutrition.

[31]  G. Maskarinec,et al.  Urinary isoflavone excretion as a compliance measure in a soy intervention among young girls: a pilot study , 2005, European Journal of Clinical Nutrition.

[32]  J. Sjövall,et al.  Soya--a dietary source of the non-steroidal oestrogen equol in man and animals. , 1984, The Journal of endocrinology.

[33]  A. Blake,et al.  Plasma and urinary phyto-oestrogens as biomarkers of intake: validation by duplicate diet analysis , 2004, British Journal of Nutrition.

[34]  H. Adlercreutz,et al.  Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women , 2004, European Journal of Clinical Nutrition.

[35]  H. Adlercreutz,et al.  Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. , 2000, Journal of epidemiology.

[36]  C. Manach,et al.  One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women , 2006, European Journal of Clinical Nutrition.

[37]  J. Potter,et al.  Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  R. Patterson,et al.  Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. , 2003, The American journal of clinical nutrition.

[39]  M. Cotterchio,et al.  Adolescent dietary phytoestrogen intake and breast cancer risk (Canada) , 2006, Cancer Causes & Control.

[40]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[41]  A. Franke,et al.  Isoflavones in breastfed infants after mothers consume soy. , 2006, The American journal of clinical nutrition.

[42]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[43]  K. Setchell,et al.  The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. , 2002, The Journal of nutrition.

[44]  K. Anderson,et al.  Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. , 1996, Nutrition and cancer.

[45]  Bing-Sheng Yu,et al.  RP-HPLC determination of puerarin in Chinese traditional medicinal preparations containing pueraria. , 2002, Journal of pharmaceutical and biomedical analysis.

[46]  S. Azen,et al.  Isoflavone Soy Protein Supplementation and Atherosclerosis Progression in Healthy Postmenopausal Women: A Randomized Controlled Trial , 2011, Stroke.

[47]  A. Franke,et al.  High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. , 1994, Journal of chromatography. B, Biomedical applications.

[48]  J. Lampe,et al.  Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. , 2001, The Journal of nutrition.

[49]  G. Maskarinec,et al.  Urinary Sex Steroid Excretion Levels During a Soy Intervention Among Young Girls: A Pilot Study , 2005, Nutrition and cancer.

[50]  Cancer Epidemiol Biomarkers Prev , 2004 .

[51]  S. Murphy,et al.  Isoflavone content of foods with soy additives , 2005 .

[52]  J. Lampe.  Emerging research on equol and cancer. , 2010, The Journal of nutrition.

[53]  M. R. Thomas,et al.  Growth and protein status of term infants fed soy protein formulas differing in protein content. , 1994, Journal of the American College of Nutrition.

[54]  K. Setchell,et al.  Method of defining equol-producer status and its frequency among vegetarians. , 2006, The Journal of nutrition.

[55]  A. Franke,et al.  Rapid HPLC Analysis of Dietary Phytoestrogens from Legumes and from Human Urine , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[56]  Ashutosh Kumar Singh,et al.  Composition, red blood cell uptake, and serum protein binding of phytoestrogens extracted from commercial kudzu-root and soy preparations. , 2002, Journal of medicinal food.

[57]  J. Estroff,et al.  Ultrasonographic patterns of reproductive organs in infants fed soy formula: comparisons to infants fed breast milk and milk formula. , 2010, The Journal of pediatrics.

[58]  A. Franke,et al.  Determinants for Urinary and Plasma Isoflavones in Humans After Soy Intake , 2004, Nutrition and cancer.

[59]  P. Murphy,et al.  Solvent extraction selection in the determination of isoflavones in soy foods. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[60]  Erwin Walz.  Isoflavon‐ und Saponin‐Glucoside in Soja hispida , 1931 .

[61]  K. Barnes,et al.  Isoflavone aglycon and glucoconjugate content of high- and low-soy U.K. foods used in nutritional studies. , 2002, Journal of agricultural and food chemistry.

[62]  P. Murphy,et al.  Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. , 1994, The Journal of nutrition.

[63]  A. Franke,et al.  Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[64]  C. Nagata,et al.  Dietary and Lifestyle Correlates of Urinary Excretion Status of Equol in Japanese Women , 2007, Nutrition and cancer.

[65]  A. Wu,et al.  Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. , 2003, Carcinogenesis.

[66]  W. Mack,et al.  Equol production changes over time in postmenopausal women. , 2012, The Journal of nutritional biochemistry.

[67]  G. Maskarinec,et al.  Urinary isoflavonoid excretion is similar after consuming soya milk and miso soup in Japanese-American women , 2008, British Journal of Nutrition.

[68]  K. Setchell,et al.  Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. , 2003, The American journal of clinical nutrition.

[69]  L. Wilkens,et al.  Oral Antibiotics Decrease Urinary Isoflavonoid Excretion in Children After Soy Consumption , 2007, Nutrition and cancer.

[70]  A. Franke,et al.  Phytoestrogenic isoflavonoids in epidemiologic and clinical research. , 2009, Drug testing and analysis.

[71]  W. Mack,et al.  Urine Accurately Reflects Circulating Isoflavonoids and Ascertains Compliance During Soy Intervention , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[72]  G. Williamson,et al.  Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase , 2000, FEBS letters.

[73]  R. Chiou,et al.  GC-MS determined distribution of urinary equol producers as affected by age, gender, and repeated ingestions of soymilk. , 2010, Journal of food science.

[74]  M. Pike,et al.  Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. , 2002, Carcinogenesis.

[75]  M. Blatter,et al.  Growth of Newborn, Term Infants Fed Soy Formulas For 1 Year , 1999, Clinical pediatrics.

[76]  A. Franke,et al.  Urinary Isoflavones Are Increased in Adults, But Decreased in Children, Consuming Soy When on Oral Antibiotic Therapy , 2008, Nutrition and cancer.

[77]  H. Adlercreutz,et al.  Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. , 2004, The Journal of nutrition.

[78]  E. D. Walter.  Genistin (an Isoflavone Glucoside) and its Aglucone, Genistein, from Soybeans , 1941 .

[79]  K. Anderson,et al.  Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. , 1995, Nutrition and cancer.